Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.36594 | 85 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.44632 | 85 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.7023 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.05506 | 88 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.33297 | 84 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.81971 | 83 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.35027 | 86 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.58579 | 87 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.31746 | 85 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.32491 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.3173 | 85 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.45086 | 85 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.32908 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.26051 | 85 |